| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 05/18/2012 | WO2012062366A1 Compositions comprising wnt inhibitors for treating cancer |
| 05/18/2012 | WO2011139256A3 Stable rosuvastatin formulations |
| 05/18/2012 | WO2011128625A3 Divisible oral pharmaceutical compositions |
| 05/18/2012 | WO2011098698A9 Argon-based inhalable gaseous medicament against peripheral organ deficiencies or failures |
| 05/18/2012 | CA2817420A1 Combination therapy with an antitumor alkaloid |
| 05/18/2012 | CA2815492A1 Use of 2-carboxamide cycloamino urea derivatives in the treatment of egfr dependent diseases or diseases that have acquired resistance to agents that target egfr family members |
| 05/18/2012 | CA2814828A1 Method of treatment for mental disorders |
| 05/17/2012 | US20120122897 Methods of treating patients suffering from movement disorders |
| 05/17/2012 | US20120122874 Combination of a sedative and a neurotransmitter modulator, and methods for treating depression |
| 05/17/2012 | US20120122777 Diagnostic agent for ischemic heart disease risk group |
| 05/17/2012 | US20120121664 Gastric Acid Secretion Inhibiting Composition |
| 05/17/2012 | US20120121620 Anti-estrogen and immune modulator combinations for treating breast cancer |
| 05/17/2012 | US20120121618 Predicting And Treating Prostate Cancer |
| 05/17/2012 | US20120121606 Antibodies that immunospecifically bind to b lymphocyte stimulator protein |
| 05/17/2012 | US20120121601 Mammalian receptor proteins; related reagents and methods |
| 05/17/2012 | US20120121556 Methods of using regenerative cells to promote wound healing |
| 05/16/2012 | EP2453009A1 Methods of organ regeneration |
| 05/16/2012 | EP2452891A2 Complementary personal lubricant compositions and delivery system |
| 05/16/2012 | EP2452685A1 Buffered compositions for dialysis |
| 05/16/2012 | EP2452680A1 Acid pump antagonist for treatment of diseases associated with abnormal gastrointestinal movement |
| 05/16/2012 | EP2451944A1 Permanently charged sodium and calcium channel blockers as anti-inflammatory agents |
| 05/16/2012 | EP2451795A1 Compositions and methods for enhancing virus efficacy |
| 05/16/2012 | EP2451482A1 Combination therapy for the treatment of diabetes |
| 05/16/2012 | EP2451459A1 Method of reducing multi-drug resistance using inositol tripyrophosphate |
| 05/16/2012 | EP2451451A1 Hdac 6 inhibitor-based methods for treating cancer |
| 05/16/2012 | EP2451299A1 Methods and compositions for treating thyroid-related medical conditions with reduced folates |
| 05/16/2012 | EP2451276A1 Methods of treating pdnv and ponv with extended release ondansetron compositions |
| 05/16/2012 | EP2254573B1 Compositions comprising phytoestrogens selective for estrogen beta receptor and dietary fibres |
| 05/16/2012 | EP1997486B1 Therapeutic agent for functional brain disease |
| 05/16/2012 | EP1919466B9 Formulations for treatment of lipoprotein abnormalities comprising a statin and a methylnicotinamide derivative |
| 05/16/2012 | DE102010051430A1 The agent useful for treating an infection caused by a virus from the group including human papillomavirus, comprises a neuraminidase inhibitor as an essential component |
| 05/16/2012 | CN1668763B 1L1RL-1 as a cardiovascular disease marker and therapeutic target |
| 05/16/2012 | CN1575338B Bv8 nucleic acids and polypeptides with mitogenic activity |
| 05/16/2012 | CN102458473A Method for treating or ameliorating mucocutaneous or ocular toxicities |
| 05/16/2012 | CN102458472A Pharmaceutical composition, food or beverage, and methods for these products |
| 05/16/2012 | CN102458387A New compositions for treating cmt and related disorders |
| 05/16/2012 | CN102458386A 用于紧急避孕的药物组合物 Pharmaceutical compositions for emergency contraception |
| 05/16/2012 | CN102458362A Topical retinoid solutions |
| 05/16/2012 | CN102458351A Agent for preventing or treating abnormality in skin water permeation function |
| 05/16/2012 | CN102451467A Compositions comprising a retinoid and an nfkb-inhibitor and their methods of use |
| 05/16/2012 | CN102451428A Chinese medicinal composition for treating rheumatoid arthritis |
| 05/16/2012 | CN102451249A Drug for treating burn and scald, and application thereof |
| 05/16/2012 | CN102451167A H1 accepter antagonist oral cavity disintegrating tablet and preparation method thereof |
| 05/16/2012 | CN102451166A Setron medicament oral cavity disintegrating tablet and preparation method thereof |
| 05/16/2012 | CN102451161A Dispersible tablets containing cholesterol absorption inhibitor and lipid regulating drug, and application thereof |
| 05/16/2012 | CN101522220B Long-term enteral feed for maintenance |
| 05/16/2012 | CN101522191B Angiotensin ii receptor antagonist for the prevention or treatment of systemic diseases in cats |
| 05/16/2012 | CN101115506B Oral treatment compositions containing an anti-adhesion agent, antibacterial agent and incompatible compound |
| 05/15/2012 | US8178493 Method for inducing angiogenesis in a heart of a patient |
| 05/15/2012 | US8178308 Use of IL-27 agonists to increase interferon-gamma production |
| 05/15/2012 | US8178115 Method and composition for the treatment of scars |
| 05/15/2012 | CA2558941C Enhancement of activity and/or duration of action of selected anti-inflammatory steroids |
| 05/15/2012 | CA2532199C Parasiticidal composition comprising a salicylanilide anti-parasitic compound |
| 05/15/2012 | CA2496329C Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof |
| 05/15/2012 | CA2487332C Quaternised ammonium cyclodextrin compounds for use as antimicrobial agents, preservatives and penetration enhancers |
| 05/15/2012 | CA2479351C Topical composition comprising a cyclofructan, a carrier and a drug |
| 05/15/2012 | CA2478223C Combinations comprising epothilone derivatives and alkylating agents |
| 05/15/2012 | CA2474964C An insulin improving agent containing adiponectin |
| 05/15/2012 | CA2461227C Methods and compositions to determine the chemosensitizing dose of suramin used in combination therapy |
| 05/15/2012 | CA2449139C Acid controlled induced viscosity fiber system and uses thereof |
| 05/15/2012 | CA2449053C Dual viscosity fiber system and uses thereof |
| 05/15/2012 | CA2448933C A retinoic acid metabolizing cytochrome p450 |
| 05/15/2012 | CA2378243C Methods for treating or preventing pain and anxiety |
| 05/15/2012 | CA2367291C Amplification of cyp24 and uses thereof |
| 05/15/2012 | CA2358400C Methods for treating conditions associated with the accumulation of excess extracellular matrix |
| 05/10/2012 | WO2012061060A1 Use of teriflunomide for treating brain atrophy |
| 05/10/2012 | WO2012060448A1 Combined pharmaceutical composition as antifungal agent |
| 05/10/2012 | WO2012060397A1 Preventive or therapeutic agent for pain associated with herpes zoster in acute phase |
| 05/10/2012 | WO2012059572A1 COMBINATION OF ATOMIC QUANTUM CLUSTERS (AQCs) AND ANTINEOPLASIC DRUGS, AND ITS USE IN THE PREVENTION AND/OR TREATMENT OF CELL PROLIFERATIVE DISORDERS |
| 05/10/2012 | WO2012059571A1 USE OF ATOMIC QUANTUM CLUSTERS (AQCs) IN THE PREVENTION OF AUTOIMMUNE DISEASES |
| 05/10/2012 | WO2012059570A1 USE OF ATOMIC QUANTUM CLUSTERS (AQCs) IN THE PREVENTION OF VIRAL INFECTIONS |
| 05/10/2012 | WO2012059416A1 Pharmaceutical combinations for the treatment of metabolic disorders |
| 05/10/2012 | WO2012059412A1 Colouring mousse composition based on an alkanolamine mixture including monoethanolamine |
| 05/10/2012 | WO2012059410A1 Dye composition having a low content of ammonia |
| 05/10/2012 | WO2012059407A1 Foam dye composition comprising a monosaccharide or disaccharide |
| 05/10/2012 | WO2012059158A1 Composition and drug containing omega-3 fatty acids, and a modulator |
| 05/10/2012 | WO2012032360A3 Novel use |
| 05/10/2012 | US20120115921 Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment |
| 05/10/2012 | US20120115854 Pharmaceutical composition containing antihypertensive agents |
| 05/10/2012 | US20120114709 Formulations for use in inhaler devices |
| 05/10/2012 | US20120114708 Integrin heterodimer and an alpha subunit thereof |
| 05/10/2012 | US20120114660 Antibodies Against LLG Polypeptides of the Triacylglycerol Lipase Family |
| 05/10/2012 | US20120114604 Combinations for HCV Treatment |
| 05/10/2012 | US20120114596 Tslp promotes immune evasion and persistence of viruses |
| 05/10/2012 | US20120114556 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
| 05/10/2012 | DE102010050570A1 Zusammensetzung und Arzneimittel enthaltend ω-3-Fettsäuren sowie einen Inhibitor des NF-κB-Transkriptionsfaktors Composition and medicines containing ω-3 fatty acids as well as an inhibitor of NF-kB transcription factor |
| 05/10/2012 | CA2819997A1 Preventive or therapeutic agent for pain associated with herpes zoster in acute phase |
| 05/10/2012 | CA2813671A1 Pharmaceutical combinations for the treatment of metabolic disorders |
| 05/09/2012 | EP2450057A1 Novel forms of CDDO methyl ester |
| 05/09/2012 | EP2450048A2 Compositions and methods for reestablishing gene transcription through inhibition of DNA methylation and histone deacetylase |
| 05/09/2012 | EP2450045A1 Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses |
| 05/09/2012 | EP2450037A1 Methods, compositions and articles of manufacture for contributing to the treatment of cancers |
| 05/09/2012 | EP2450032A2 Microvesicles derived from nucleated, mammalian cells and use thereof |
| 05/09/2012 | EP2448577A1 Compositions containing berberine or analogs thereof for treating rosacea or red face related skin disorders |
| 05/09/2012 | EP2448572A1 Methods of identifying a patient population eligible for treatment with nitric oxide via inhalation |
| 05/09/2012 | EP2448570A1 L-serine to be used as a drug for preventing and/or treating an inflammatory response of the skin |
| 05/09/2012 | EP1715863B1 Enhancement of ampakine-induced facilitation of synaptic responses by cholinesterase inhibitors |
| 05/09/2012 | EP1672062B1 Method and kit for detecting proliferative diseases causing sclerosis, preventive and/or remedy for proliferative diseases causing sclerosis and method and kit for identifying substance efficacious in preventing and/or treating proliferative diseases causing sclerosis |
| 05/09/2012 | EP1631281B1 Phosphodiesesterase 4 inhibitors for the treatment of a cognitive deficit |
| 05/09/2012 | EP1427830B1 Bv8 NUCLEIC ACIDS AND POLYPEPTIDES WITH MITOGENIC ACTIVITY |